AU766787B2 - Meth1 and meth2 polynucleotides and polypeptides - Google Patents

Meth1 and meth2 polynucleotides and polypeptides Download PDF

Info

Publication number
AU766787B2
AU766787B2 AU24641/99A AU2464199A AU766787B2 AU 766787 B2 AU766787 B2 AU 766787B2 AU 24641/99 A AU24641/99 A AU 24641/99A AU 2464199 A AU2464199 A AU 2464199A AU 766787 B2 AU766787 B2 AU 766787B2
Authority
AU
Australia
Prior art keywords
seq
amino acids
polypeptide
meth2
garni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU24641/99A
Other languages
English (en)
Other versions
AU2464199A (en
Inventor
Gregg A Hastings
Luisa Iruela-Arispe
Steven M. Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Beth Israel Deaconess Medical Center
Original Assignee
Human Genome Sciences Inc
Beth Israel Deaconess Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Beth Israel Deaconess Medical Center filed Critical Human Genome Sciences Inc
Publication of AU2464199A publication Critical patent/AU2464199A/en
Application granted granted Critical
Publication of AU766787B2 publication Critical patent/AU766787B2/en
Priority to AU2004200046A priority Critical patent/AU2004200046A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU24641/99A 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides Ceased AU766787B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2004200046A AU2004200046A1 (en) 1998-01-23 2004-01-07 Meth1 and Meth2 Polynucleotides and Polypeptides

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7229898P 1998-01-23 1998-01-23
US60/072298 1998-01-23
US9853998P 1998-08-28 1998-08-28
US60/098539 1998-08-28
PCT/US1999/001313 WO1999037660A1 (en) 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2004200046A Division AU2004200046A1 (en) 1998-01-23 2004-01-07 Meth1 and Meth2 Polynucleotides and Polypeptides

Publications (2)

Publication Number Publication Date
AU2464199A AU2464199A (en) 1999-08-09
AU766787B2 true AU766787B2 (en) 2003-10-23

Family

ID=26753215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24641/99A Ceased AU766787B2 (en) 1998-01-23 1999-01-22 Meth1 and meth2 polynucleotides and polypeptides

Country Status (9)

Country Link
EP (1) EP1049708A4 (enExample)
JP (1) JP2002501077A (enExample)
KR (1) KR20010086224A (enExample)
CN (1) CN1292796A (enExample)
AU (1) AU766787B2 (enExample)
CA (1) CA2319109A1 (enExample)
MX (1) MXPA00007165A (enExample)
NZ (1) NZ505855A (enExample)
WO (1) WO1999037660A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416974B1 (en) 1997-08-06 2002-07-09 Millennium Pharmaceuticals, Inc. Tango 71 nucleic acids
DE19806581A1 (de) * 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Sequenzen eines Ih-Ionenkanals und deren Verwendung
US6649377B1 (en) * 1999-05-10 2003-11-18 Syntex (U.S.A.) Llc Human aggrecanase and nucleic acid compositions encoding the same
ATE444971T1 (de) * 1999-06-09 2009-10-15 Genentech Inc Zusammensetzungen und verfahren für die tumor- behandlung
US6395889B1 (en) * 1999-09-09 2002-05-28 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding human protease homologs
EP1892250A3 (en) * 2000-01-31 2008-09-17 Munin Corporation CYR61 compositions and methods
WO2001074852A2 (en) * 2000-03-31 2001-10-11 Bayer Corporation Protein having activity as an angiogenesis modulator
JP2002330761A (ja) * 2000-04-26 2002-11-19 Pfizer Prod Inc Ａｄａｍｔｓポリペプチド、それをコードする核酸、及びその使用
JP2004524003A (ja) * 2000-06-29 2004-08-12 コリクサ コーポレイション 肺癌の治療および診断のための組成物および方法
IL158293A0 (en) 2001-04-10 2004-05-12 Agensys Inc Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
AU2002364161A1 (en) 2001-12-12 2003-06-23 Aventis Pasteur Limited Enhancement of the immune response using cd36-binding domain
ATE441713T1 (de) 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung
JP5606322B2 (ja) 2008-10-20 2014-10-15 昇志 佐藤 腫瘍抗原ペプチド及びその利用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565858B2 (en) * 1997-06-03 2003-05-20 Kureha Chemical Industry Co., Ltd. Human ADAMTS-1 protein and pharmaceutical composition
US6416974B1 (en) * 1997-08-06 2002-07-09 Millennium Pharmaceuticals, Inc. Tango 71 nucleic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUNO ET AL, BIOL CHEM 1997 V272(1),P556-562 *

Also Published As

Publication number Publication date
KR20010086224A (ko) 2001-09-10
CA2319109A1 (en) 1999-07-29
EP1049708A4 (en) 2002-09-04
AU2464199A (en) 1999-08-09
CN1292796A (zh) 2001-04-25
WO1999037660A1 (en) 1999-07-29
WO1999037660A9 (en) 1999-10-14
MXPA00007165A (es) 2002-06-21
JP2002501077A (ja) 2002-01-15
NZ505855A (en) 2005-01-28
EP1049708A1 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
US6448230B1 (en) Testis expressed polypeptide
EP1039801A1 (en) 207 human secreted proteins
WO1998039448A9 (en) 186 human secreted proteins
WO1998045712A2 (en) 20 human secreted proteins
JPH10510986A (ja) メタロプロテイナーゼ−４のヒト組織インヒビター
WO1998056804A1 (en) 86 human secreted proteins
WO1998054206A1 (en) 32 human secreted proteins
US20040002066A1 (en) 36 human secreted proteins
MXPA00007165A (es) Polinucleotidos y polipeptidos de meth1 y meth2.
US20040002449A1 (en) METH1 and METH2 polynucleotides and polypeptides
US20030092900A1 (en) Meth1 and Meth2 polynucleotides and polypeptides
US20040024192A1 (en) 19 human secreted proteins
US6806351B2 (en) Secreted protein HBJFE12
US20030144492A1 (en) 101 human secreted proteins
CA2298852A1 (en) 83 human secreted proteins
CN1703422A (zh) Meth1和meth2多核苷酸及多肽
US20030176681A1 (en) 148 human secreted proteins
JP2000106889A (ja) 分泌マウスタンパク質ｓＦＲＰ―１に類似した新規ヒト遺伝子
EP1042346A1 (en) 86 human secreted proteins
US20020123619A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20040185440A9 (en) 125 human secreted proteins
AU2004200046A1 (en) Meth1 and Meth2 Polynucleotides and Polypeptides
EP0972030A2 (en) 70human secreted proteins

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)